{
  "image_filename": "figure_p2_det_1_000.png",
  "image_path": "CDC_Influenza_vaccines/extracted/figures/figure_p2_det_1_000.png",
  "image_type": "Figure",
  "page_number": 2,
  "block_id": "det_1_000",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "Table listing trade names (Fluad Quadrivalent, Flublok Quadrivalent, FluMist Quadrivalent), their presentations, age indications, antigen content per dose, administration route, and mercury content for quadrivalent influenza vaccines. The table only describes vaccine formulations and characteristics and does not mention any pivotal trial or comparison between Flublok and Fluarix, so it does not support the claim. Note: The image is clear but only shows product attributes without study or comparator information.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Table listing trade names (Fluad Quadrivalent, Flublok Quadrivalent, FluMist Quadrivalent), their presentations, age indications, antigen content per dose, administration route, and mercury content for quadrivalent influenza vaccines.",
    "evidence_found": null,
    "reasoning": "The table only describes vaccine formulations and characteristics and does not mention any pivotal trial or comparison between Flublok and Fluarix, so it does not support the claim.",
    "confidence_notes": "The image is clear but only shows product attributes without study or comparator information."
  }
}